Concerns Rise Over Antipsychotic Drug Misuse in Nursing Homes
The use of antipsychotic medications in nursing homes continues to be a significant concern, with a novel pair of reports from the Department of Health and Human Services (HHS) Office of Inspector General (OIG) highlighting troubling practices. Released on Thursday, March 18, 2026, the reports detail how these powerful drugs are often misused, sometimes as chemical restraints and how facilities may be inappropriately diagnosing residents with schizophrenia to justify their use. This isn’t a new issue. investigations and research over the past two decades have repeatedly pointed to these problems, but the latest findings aim to provide more detailed insight into the experiences of residents and caregivers, and to push for stronger regulatory oversight from the Centers for Medicare and Medicaid Services (CMS).
The HHS OIG reports paint a stark picture of a system where antipsychotic drugs are sometimes employed not for their intended purpose – treating conditions like schizophrenia – but to manage behavioral symptoms and make staffing easier. This practice, the reports suggest, often occurs without adequate safeguards to protect patients from the drugs’ potentially harmful side effects. The reports indicate that some nursing homes are artificially inflating their quality ratings by assigning schizophrenia diagnoses to residents who may actually be suffering from dementia, thereby masking the inappropriate use of antipsychotics. This manipulation of diagnostic codes allows facilities to appear to be providing more appropriate care than they actually are, potentially misleading families, and regulators.
A History of Concern and Prior Investigations
The issue of antipsychotic drug misuse in nursing homes has been a recurring theme in healthcare oversight for years. A 2020 investigation by the House Ways and Means Committee uncovered similar concerns, and the HHS OIG itself previously highlighted these trends in a 2022 report examining long-term trends of psychotropic drug use in nursing homes. That report detailed concerning patterns of psychotropic medication use among Medicare beneficiaries in nursing homes. Academic research has also consistently demonstrated the risks associated with inappropriate antipsychotic use in elderly populations, particularly those with dementia. One study published in 2019, for example, explored the association between antipsychotic use and increased mortality risk in dementia patients. Another research article further details the complexities of this issue.
The current reports from the HHS OIG, available as issue briefs here and here, are not necessarily breaking new ground in terms of identifying the problem, but rather aim to provide a more granular understanding of the issue and to bolster the case for stronger CMS regulation. The authors emphasize the need to understand the experiences of both residents and caregivers to effectively address the problem.
The Risks of Antipsychotic Medications in Elderly Patients
Antipsychotic drugs, while effective in treating certain mental health conditions, carry significant risks, particularly for elderly individuals with dementia. These risks include increased risk of stroke, falls, and even death. The drugs can also cause metabolic changes that contribute to weight gain, diabetes, and cardiovascular problems. For patients with dementia, antipsychotics can worsen cognitive impairment and reduce quality of life. The inappropriate use of these medications, represents a serious threat to the health and well-being of vulnerable nursing home residents.
The concern isn’t simply about the drugs themselves, but also about the reasons they are being prescribed. When used as a chemical restraint – to control behavior rather than treat a diagnosed condition – antipsychotics are often administered without proper evaluation of alternative interventions, such as behavioral therapies or increased staffing levels. This practice not only exposes residents to unnecessary risks but also undermines their dignity and autonomy.
Medicare’s Proposed Staffing Rules and Ongoing Debate
The spotlight on nursing home care quality comes as the Biden administration is considering new rules aimed at improving staffing levels in these facilities. In late 2023, Medicare proposed regulations that would require long-term care facilities to have a registered nurse (RN) on site 24/7, as well as minimum staffing ratios of 0.55 RN hours per resident day and 2.45 nursing assistant hours per resident day. However, these proposed rules have faced criticism from some Medicare experts, who argue they may be unrealistic or financially unsustainable for many facilities. Current federal law already mandates an RN on duty for at least 8 consecutive hours each day and a licensed nurse (RN or licensed practical nurse) on site 24/7.
The debate over staffing levels highlights the complex challenges facing the nursing home industry. While increased staffing is widely seen as a crucial step towards improving care quality, facilities often struggle to recruit and retain qualified personnel, particularly in rural areas. The financial pressures on nursing homes, coupled with the increasing demands of an aging population, create a difficult environment for providing optimal care.
Finding Quality Nursing Home Care
For families seeking nursing home care for their loved ones, navigating the system can be daunting. Medicare provides a resource for comparing care quality at nursing homes near you through its Care Compare website. This tool allows users to view ratings based on health inspections, staffing levels, and quality measures. However, it’s important to remember that these ratings are not always a perfect indicator of care quality, and families should also consider visiting facilities in person, speaking with staff and residents, and asking detailed questions about their policies and procedures.
When evaluating a nursing home, it’s crucial to inquire about their policies regarding the use of antipsychotic medications. Families should ask how the facility assesses residents for potential side effects, what alternative interventions are used to manage behavioral symptoms, and how they ensure that medications are prescribed appropriately. Advocating for a loved one’s rights and being actively involved in their care plan can help to prevent unnecessary or inappropriate medication use.
Looking Ahead
The HHS OIG reports serve as a renewed call to action for CMS to strengthen its oversight of nursing home practices and to ensure that residents receive the safe, effective, and compassionate care they deserve. The agency is expected to respond to the reports with a plan for addressing the identified concerns. The ongoing debate over Medicare staffing rules will also likely continue, as stakeholders work to find a balance between improving care quality and ensuring the financial viability of nursing homes. The future of long-term care in the United States depends on finding solutions that prioritize the well-being of vulnerable seniors and protect them from harm.
The next step in this process will be CMS’s formal response to the OIG’s recommendations, which is anticipated within the next few months. Families and advocates are encouraged to stay informed about these developments and to continue to advocate for improved nursing home care. Share your thoughts and experiences in the comments below.